Literature DB >> 8914763

Studies of proliferative responses by long-term-cryopreserved peripheral blood mononuclear cells to bacterial components associated with periodontitis.

G A Miller1, M F Hickey, M M D'Alesandro, B K Nicoll.   

Abstract

Freezing techniques provide a means for repeating and extending immunological assays with frozen aliquots of an individual's peripheral blood mononuclear cell fraction. Lymphocytes which are stored frozen for a limited time retain their ability to respond to polyclonal B-cell activators, mitogens, and antigens of dental interest. Our studies extend these previous findings by determining lymphocyte functional activity following frozen storage for up to 100 weeks. In addition, the autologous immune response was measured by spontaneous lymphocyte proliferation following 0, 1, 40, and 60 weeks of frozen storage. Peak responses for all individuals occurred at day 7 of incubation. The lymphocyte proliferative response to the superantigens toxic shock syndrome toxin-1 (TSST-1) and Staphylococcus enterotoxin A (SEA) were not changed after 100 weeks of frozen storage. Maximum responses varied among the individuals but occurred at equivalent stimulator concentrations. However, slopes generated from data obtained following 0, 4, 13, 20, 30, 50, 88, and 100 weeks of frozen storage showed no significant deviation from zero (P > 0.05) for all individuals tested. After 100 weeks of storage, the total changes in proliferative activity (counts per minute per week) were -2.1% +/- 16.8% and -5.5% +/- 17.0% for TSST-1 and SEA, respectively. The lymphocyte proliferative responses to pokeweed mitogen, concanavalin A, and sonicates of two periodontal pathogens (Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans) following frozen storage were similar to those with TSST-1 and SEA. These results indicate that peripheral blood mononuclear cells stored frozen may serve as appropriate controls to monitor changes in the disease state long-term periodontal treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8914763      PMCID: PMC170435          DOI: 10.1128/cdli.3.6.710-716.1996

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  44 in total

1.  Cryopreservation of human lymphocyte function as measured by in vitro assays.

Authors:  R K Oldham; J H Dean; G B Cannon; J R Ortaldo; G Dunston; F Applebaum; J L McCoy; J Djeu; R B Herberman
Journal:  Int J Cancer       Date:  1976-08-15       Impact factor: 7.396

2.  Predominant cultivable microbiota in periodontosis.

Authors:  M G Newman; S S Socransky
Journal:  J Periodontal Res       Date:  1977-03       Impact factor: 4.419

3.  T lymphocyte subsets in the inflamed gingiva of human adult periodontitis.

Authors:  H Okada; Y Kassai; T Kida
Journal:  J Periodontal Res       Date:  1984-11       Impact factor: 4.419

4.  E-rosette dormation of fresh versus frozen-thawed lymphocytes from leukemic patients and normal individuals.

Authors:  G J Polizzi; E Cohen; S G Gregory
Journal:  Cryobiology       Date:  1978-02       Impact factor: 2.487

5.  Identification of lymphocyte subpopulations in E-RFC-enriched and E-RFC-depleted cell fractions of fresh and cryopreserved lymphocytes.

Authors:  R L Bolhuis; H R Schuit
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

6.  The use of cryopreserved lymphocytes in the leukocyte adherence inhibition assay. I. Evaluation of specificity of responses in cancer patients.

Authors:  S R Waldman; R H Yonemoto
Journal:  Int J Cancer       Date:  1978-05-15       Impact factor: 7.396

7.  Cryopreservation of immunological memory and other lymphoid cell functions.

Authors:  D Naor; C O'Toole
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

8.  The use of viable frozen lymphocytes for studies in human tumor immunology.

Authors:  S H Golub; H L Sulit; D L Morton
Journal:  Transplantation       Date:  1975-03       Impact factor: 4.939

9.  Clinical and immunologic studies of disseminated BCG infection.

Authors:  S A Rosenberg; C Seipp; H F Sears
Journal:  Cancer       Date:  1978-05       Impact factor: 6.860

10.  Sequential examination of lymphocyte proliferative capacity in patients with malignant melanoma receiving BCG immunotherapy.

Authors:  S H Golub; A B Forsythe; D L Morton
Journal:  Int J Cancer       Date:  1977-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.